2Xideas AG Increases ResMed Inc. Stake by 11.2%

The institutional investor now owns over 83,000 shares of the medical equipment provider.

Mar. 14, 2026 at 7:04am

Got story updates? Submit your updates here. ›

2Xideas AG, an institutional investor, has increased its holdings in ResMed Inc. (NYSE:RMD) by 11.2% during the 3rd quarter, according to a recent SEC filing. The firm now owns 83,611 shares of the medical equipment provider's stock, making it one of the company's top 5 shareholders.

Why it matters

ResMed is a leading global provider of medical devices and cloud-connected solutions for sleep apnea and other respiratory conditions. The increase in 2Xideas AG's stake suggests the institutional investor sees long-term value in ResMed's business and growth potential.

The details

According to the filing, 2Xideas AG purchased an additional 8,397 shares of ResMed during the 3rd quarter, bringing its total position to 83,611 shares. This represents approximately 0.06% of ResMed's outstanding shares and makes 2Xideas AG's holding the company's 5th largest position, accounting for 4.8% of its overall portfolio.

  • 2Xideas AG increased its ResMed holdings during the 3rd quarter of 2026.

The players

2Xideas AG

An institutional investor that has increased its stake in ResMed Inc. to become one of the company's top 5 shareholders.

ResMed Inc.

A global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions.

Got photos? Submit your photos here. ›

The takeaway

The increase in 2Xideas AG's stake in ResMed suggests the institutional investor sees long-term growth potential in the medical device company, which is a leader in sleep apnea and respiratory care solutions.